Blood tests may prevent relapse in breast cancer patients 18 Nov 2022 An innovative trial to detect relapse in breast cancer patients with circulating tumour DNA (ctDNA) has opened at our partner hospital, The Royal Marsden NHS Foundation Trust. The TRAK-ER trial, led by researchers at The Royal Marsden and The Institute of Cancer Research, London, will establish a circulating tumour DNA (ctDNA) surveillance programme for over 1,000 patiets with ER positive breast cancer who are currently receiving hormone therapy to reduce their risk of cancer returning. Find out more Show/Hide
Three-drug combination moves forward for advanced breast cancer 11 Mar 2021 A combination of three drugs is safe and shows signs of effectiveness in treating some patients with previously treated advanced breast cancer, a clinical trial shows. Find out more Show/Hide
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer 28 Jan 2021 An already approved breast cancer drug could bring hope to thousands of UK women who have an aggressive form of breast cancer, new research has found. Find out more Show/Hide
ICR responds to NICE approval of palbociclib for treating advanced breast cancer after hormone therapy 28 Nov 2019
ESMO 2018: Major trial shows targeted drug – palbociclib – extends breast cancer survival 20 Oct 2018